Miyako Kishimoto

Summary

Publications

  1. pmc Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes
    Miyako Kishimoto
    Department of Diabetes and Metabolic Medicine, Center Hospital, and Diabetes and Metabolism Information Center, Diabetes Research Center, National Center for Global Health and Medicine, 1 21 1 Toyama, Shinjuku ku, Tokyo, 162 8655, Japan
    Diabetes Ther 3:11. 2012
  2. pmc A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers
    Miyako Kishimoto
    Department of Diabetes and Metabolic Medicine, Center Hospital, Diabetes and Metabolism Information Center, 1 21 1 Toyama, Shinjuku ku, Tokyo, 162 8655, Japan
    Cardiovasc Diabetol 10:115. 2011
  3. ncbi request reprint A case of malignant insulinoma: successful control of glycemic fluctuation by replacing octreotide injections with octreotide LAR injections
    Masahide Okamoto
    Department of Diabetes and Metabolic Medicine, Center Hospital, National Center for Global Health and Medicine, Tokyo 162 8655, Japan
    Endocr J 60:951-7. 2013
  4. pmc Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular complications: a cross-sectional study
    Tetsuro Tsujimoto
    Department of Diabetes and Metabolic Medicine and Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan
    BMJ Open 1:e000139. 2011
  5. doi request reprint Autoimmune diabetes in HIV-infected patients on highly active antiretroviral therapy
    Daisuke Takarabe
    Department of Diabetes and Metabolic Medicine, AIDS Clinical Center, National Center for Global Health and Medicine, Toyama 1 21 1, Shinjuku ku, Tokyo 162 8655, Japan
    J Clin Endocrinol Metab 95:4056-60. 2010
  6. ncbi request reprint Efficacy of ezetimibe as monotherapy or combination therapy in hypercholesterolemic patients with and without diabetes
    Miyako Kishimoto
    Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Tokyo, Japan
    J Med Invest 58:86-94. 2011
  7. ncbi request reprint A morbid obese Japanese woman with a body mass index of 83.2 kg/m2: before and after sleeve gastrectomy
    Maki Goto
    Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Japan
    Intern Med 51:969-75. 2012
  8. doi request reprint A patient with diabetes and breast cancer in whom virilization was caused by a testosterone-producing mature cystic teratoma containing a Brenner tumor
    Tetsuro Tsujimoto
    Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Japan
    Am J Med Sci 341:74-7. 2011
  9. ncbi request reprint Immunohistochemical findings in the pancreatic islets of a patient with transfusional iron overload and diabetes: case report
    Miyako Kishimoto
    Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Tokyo, Japan
    J Med Invest 57:345-9. 2010
  10. pmc The Great East Japan Earthquake: Experiences and Suggestions for Survivors with Diabetes (perspective)
    Miyako Kishimoto
    Chief, Department of Diabetes and Metabolic Medicine, Center Hospital, and Diabetes and Metabolism Information Center, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan
    PLoS Curr 4:e4facf9d99b997. 2012

Collaborators

  • Mitsuhiko Noda
  • Kazuo Kubota
  • Kazunori Kasama
  • Yasushi Kaburagi
  • Miwako Honda
  • Miyako Morooka
  • Shotaro Hagiwara
  • Yoshihiko Takahashi
  • Hiroshi Kajio
  • Tetsuro Tsujimoto
  • Ritsuko Yamamoto-Honda
  • Hiroshi Noto
  • Atsushi Goto
  • Masahide Okamoto
  • Kazuki Yasuda
  • Maki Takaichi
  • Maki Goto
  • Hisako Endo
  • Takuro Shimbo
  • Daisuke Takarabe
  • Yoshihiro Edamoto
  • Makoto Tokuhara
  • Toru Igari
  • Keiichiro Osame
  • Noriko Ihana
  • Kaori Inoue
  • Takahisa Tanaka
  • Yosuke Seki
  • Kenjiro Imai
  • Yuri Kaneko
  • Yuka Kosuga
  • Hironobu Sasano
  • Michiaki Hiroe
  • Munehiro Kamimura
  • Hidemitsu Yasuda
  • Hideto Gomibuchi
  • Katsuji Teruya
  • Shinichi Oka
  • Yuka Rokukawa
  • Kunihisa Tsukada
  • Yoshimi Kikuchi

Detail Information

Publications11

  1. pmc Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes
    Miyako Kishimoto
    Department of Diabetes and Metabolic Medicine, Center Hospital, and Diabetes and Metabolism Information Center, Diabetes Research Center, National Center for Global Health and Medicine, 1 21 1 Toyama, Shinjuku ku, Tokyo, 162 8655, Japan
    Diabetes Ther 3:11. 2012
    ..To examine the efficacy of sitagliptin and miglitol when added to ongoing insulin treatment in a patient with type 2 diabetes who had undergone partial gastrectomy...
  2. pmc A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers
    Miyako Kishimoto
    Department of Diabetes and Metabolic Medicine, Center Hospital, Diabetes and Metabolism Information Center, 1 21 1 Toyama, Shinjuku ku, Tokyo, 162 8655, Japan
    Cardiovasc Diabetol 10:115. 2011
    ..Therefore, glycemic control with the combination of these drugs is warranted...
  3. ncbi request reprint A case of malignant insulinoma: successful control of glycemic fluctuation by replacing octreotide injections with octreotide LAR injections
    Masahide Okamoto
    Department of Diabetes and Metabolic Medicine, Center Hospital, National Center for Global Health and Medicine, Tokyo 162 8655, Japan
    Endocr J 60:951-7. 2013
    ..The findings of the present study showed that octreotide LAR could be useful for the long-term treatment of unresectable insulinomas. ..
  4. pmc Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular complications: a cross-sectional study
    Tetsuro Tsujimoto
    Department of Diabetes and Metabolic Medicine and Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan
    BMJ Open 1:e000139. 2011
    ..18; 95% CI 2.30 to 16.64; p<0.001). Conclusions Asymptomatic CHD with ≥50% diameter stenosis and myocardial perfusion abnormalities was detected in more than half of the patients with type 2 diabetes with vascular complications...
  5. doi request reprint Autoimmune diabetes in HIV-infected patients on highly active antiretroviral therapy
    Daisuke Takarabe
    Department of Diabetes and Metabolic Medicine, AIDS Clinical Center, National Center for Global Health and Medicine, Toyama 1 21 1, Shinjuku ku, Tokyo 162 8655, Japan
    J Clin Endocrinol Metab 95:4056-60. 2010
    ..However, no reports have described the development of autoimmune diabetes during HAART...
  6. ncbi request reprint Efficacy of ezetimibe as monotherapy or combination therapy in hypercholesterolemic patients with and without diabetes
    Miyako Kishimoto
    Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Tokyo, Japan
    J Med Invest 58:86-94. 2011
    ..However, we may interpret this result as suggesting that ezetimibe can be used in any population to lower low-density lipoprotein cholesterol levels...
  7. ncbi request reprint A morbid obese Japanese woman with a body mass index of 83.2 kg/m2: before and after sleeve gastrectomy
    Maki Goto
    Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Japan
    Intern Med 51:969-75. 2012
    ..We followed the clinical changes before and after the operation. This case provides potentially interesting information regarding operative treatment for morbid obesity in Japanese...
  8. doi request reprint A patient with diabetes and breast cancer in whom virilization was caused by a testosterone-producing mature cystic teratoma containing a Brenner tumor
    Tetsuro Tsujimoto
    Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Japan
    Am J Med Sci 341:74-7. 2011
    ..This case is extremely rare, but the case was accurately diagnosed through a comprehensive analysis...
  9. ncbi request reprint Immunohistochemical findings in the pancreatic islets of a patient with transfusional iron overload and diabetes: case report
    Miyako Kishimoto
    Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Tokyo, Japan
    J Med Invest 57:345-9. 2010
    ....
  10. pmc The Great East Japan Earthquake: Experiences and Suggestions for Survivors with Diabetes (perspective)
    Miyako Kishimoto
    Chief, Department of Diabetes and Metabolic Medicine, Center Hospital, and Diabetes and Metabolism Information Center, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan
    PLoS Curr 4:e4facf9d99b997. 2012
    ..We also recommend the creation of basic guidelines to facilitate the practical prescription of medication for diabetic patients under various conditions that may arise in the aftermath of a natural disaster...
  11. ncbi request reprint Body mass index, fasting plasma glucose levels, and C-peptide levels as predictors of the future insulin use in Japanese type 2 diabetic patients
    Atsushi Goto
    Department of Diabetes and Metabolic Medicine, International Medical Center of Japan, Toyama Hospital, Tokyo, Japan
    Endocr J 57:237-44. 2010
    ..In conclusion, this study suggests that BMI, FPG, sCPR, and uCPR are strong predictors of the future insulin use in type 2 diabetic patients...